Physician profile
Kriss E Myers
NPI 1902876972
$6,590.23
in general payments reported to CMS, 2019-2025
41 companies · $78.00 in 2025
The $78.00 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,361 · 2020: $1,794 · 2021: $2,015 · 2022: $181 · 2023: $40.17 · 2024: $121 · 2025: $78.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $239.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $709.54 | 2019-2024 | Arexvy |
| Pfizer INC. | $677.04 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $620.34 | 2019-2021 | |
| Amarin Pharma, INC. | $470.42 | 2019-2021 | |
| Allergan, INC. | $424.09 | 2019-2020 | |
| Novo Nordisk INC | $407.06 | 2019-2021 | |
| Abbvie INC. | $386.28 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $379.39 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $335.43 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $211.89 | 2019-2021 | |
| Amgen INC. | $175.63 | 2019-2021 | |
| Astellas Pharma US INC | $156.20 | 2019-2021 | |
| Tris Pharma INC | $152.74 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $149.91 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $144.99 | 2019-2020 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kriss Myers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.